Citations

Clear

186 citation(s) found for "Frantz, R".

Information-Guided Parameter Optimisation for MR Elastography Radiomics
Djebbara, Ilies , Yin, Ziying, Friismose, Ancuta Ioana , Poulsen, Frantz Rom , Hojo, Emi , Aunan‐Diop, Jan Saip , Friismose, Ancuta I , Hojo, Emi , Poulsen, Frantz Rom , Yin, Ziying

Mayo Clinic

No container title available | March 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.17.26348578 Get It

Abstract Mechanical properties of biological tissues vary across spatial scales, yet radiomics typically relies on fixed, heuristic choices for neighbourhood size, kernel geometry, and spectral content - choices that can silently reshape the feature space before any modelling begins. We introduce a label-free, information-theoretic framework for selecting extraction parameters in multi-frequency MRE radiomics. For each configuration θ - neighbourhood radius r, kernel geometry k (sphere or shell), and frequency subset f - we extract a radiomics feature matrix and score it using an objective J(θ) that integrates distributional richness (Shannon entropy), cross-frequency coherence (canonical correlation), inter-feature redundancy (Spearman correlation), and bootstrap stability. We evaluate 121 configurations per tissue in multi-frequency MRE (30-60 Hz) of human brain, liver, and a calibrated phantom, and test robustness using 10,000 Dirichlet-sampled objective weightings. Across tissues, neighbourhood aggregation is consistently preferred over voxel-wise extraction, outperforming the no-neighbourhood baseline in 98.4-100% of weightings. External validation in 100 independent brain scans acquired with a different protocol and wider frequency range (20-90 Hz) confirms a reproducible mesoscopic plateau at r = 3-5 (9-15 mm), with a modal optimum at r = 4; omitting neighbourhood analysis reduces J(θ) by 38% relative to each subject’s optimum. Frequency-subset preferences replicate across datasets, with lower frequencies most frequently selected for brain. By turning ad hoc extraction choices into an outcome-free optimisation step, this framework improves reproducibility, reduces sensitivity to heuristic parameter choices, and generalises across acquisition protocols and imaging sites.
Differentiating radiation necrosis from recurrent brain metastases using magnetic resonance elastography
Aunan‐Diop, Jan Saip , Friismose, Ancuta Ioana , Hojo, Emi , Pettersen, Jeanette Krogh, Grønhøj, Mads Hjortdal , Pedersen, Christian Bonde , Mussmann, Bo, Halle, Bo, Poulsen, F. Rom, Mussmann, Bo Redder , Poulsen, Frantz Rom , Mussmann, Bo , Friismose, Ancuta I , Hojo, Emi , Poulsen, Frantz Rom , Yin, Ziying , Petersen, Jeanette Krogh , Halle, Bo

Mayo Clinic

No container title available | March 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.04.26347674 Get It

Abstract Background Conventional MRI cannot reliably distinguish radiation necrosis (RN) from recurrent metastasis after cranial radiotherapy, as both can show similar enhancement despite different biology. We tested whether these entities are mechanically non-equivalent in vivo and separable by MRE-derived viscoelastic metrics and perilesional interface-instability features. Methods In a prospective, histopathology-anchored cohort, 11 post-radiotherapy enhancing lesions were classified as RN (n=3) or recurrent/progressive tumor (n=8). MRE was acquired at 3.0 T with single-frequency 60-Hz excitation to derive storage modulus (G′), loss modulus (G″), and complex shear modulus magnitude (|G*|). Co-primary endpoints were median tumor G′ and |G*|, each tested one-sided (RN > tumor) with Holm correction across the two co-primary tests. Median tumor G″ was tested two-sided. A prespecified secondary 6-endpoint family (absolute and tumor/NAWM-normalized G′, G″, and |G*|) was analyzed with Benjamini–Hochberg FDR control. Exploratory instability mapping in a 0–6 mm peritumoral shell generated interface-topology metrics, including convexity. Results Absolute tumor-core medians were higher in RN than tumor for |G*| (1.79 vs 1.32 kPa; Cliff’s δ=0.67; q=0.10), G′ (1.62 vs 1.09 kPa; δ=0.50; q=0.14), and G″ (0.81 vs 0.46 kPa; δ=0.75; q=0.10). NAWM normalization improved separation: tumor/NAWM |G*| (2.26 vs 1.41; δ=0.92; q=0.04) and tumor/NAWM G″ (2.67 vs 0.87; δ=1.00; q=0.04) were FDR-significant. Convexity also differentiated RN from tumor (0.49 vs 0.36; δ=1.00; MWU p=0.01). Conclusions Tumor/NAWM G″, tumor/NAWM |G*|, convexity, and tumor G″ emerged as the strongest candidate features, indicating that RN is mechanically harder and more dissipative than recurrent metastasis. Signal strength was high (Cliff’s δ up to 1.00) but should be interpreted cautiously given sample size. Exploratory analyses further suggest that instability mapping captures biologically relevant interface behavior. These findings support a mechanics-based RN-versus-recurrence framework and justify prespecified, preregistered external validation.
Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension
Reddy, Yogesh N.V., Frantz, R, Miranda, William R., Asokan, Aneesh K , Varma, Revati, Rischard, Franz , Hassoun, Paul M., Hemnes, Anna R. , Horn, E., Leopold, Jane A. , Rosenzweig, Erika B., Hill, N.S., Erzurum, Serpil C., Beck, Gerald J. , Barnard, John, Finet, J. Emanuel , Kwon, Deborah , Mathai, Stephen C., MUKHERJEE, MONICA, Borlaug, Barry A., Frantz, Robert P. , Horn, Evelyn M. , Hassoun, Paul M. , Mathai, Stephen C. , Reddy, Yogesh N.V. , Nishimura, Rick , Frantz, Robert P , Miranda, William R , Hassoun, Paul M , Horn, Evelyn M , Rosenzweig, Erika B , Hill, Nicholas S , Erzurum, Serpil C , Barnard, John , Mathai, Stephen C , Mukherjee, Monica , Tang, W H Wilson , Borlaug, Barry A , Hemnes, Anna , Rischard, Franz P , Leopold, Jane A , Miranda, William R. , Varma, Revati , Erzurum, Serpil C. , Mukherjee, Monica , Nair, K. Sreekumaran , Borlaug, Barry A.

Mayo Clinic

Circulation | February 13, 2026 | Volume: 153 | Issue: 13 | Pages: 948-962

10.1161/circulationaha.125.077606 | PMID 41685452 Get It

BACKGROUND: With pulmonary hypertension (PH), a pulmonary artery wedge pressure (PAWP)>15 mm Hg is used to diagnose left heart dysfunction, but some patients with adjudicated group 1 PH demonstrate PAWP>15 mm Hg. The primary objective of the study was to evaluate group 1 PH with high PAWP>15 mm Hg. METHODS: Patients with adjudicated group 1 PH from PVDOMICS between 2016 and 2019 were separated into high PAWP(>15 mm Hg) or normal PAWP and compared with adjudicated combined pre- and postcapillary (Cpc) PH related to heart failure with preserved ejection fraction (HFpEF). Participants underwent dynamic right heart catheterization and metabolomics. Findings were validated in 3 independent cohorts with adjudicated group 1 PH (validation cohorts 1 and 2 with exercise right heart catheterization and validation cohort 3 with resting right heart catheterization). RESULTS: Of 325 patients with group 1 PH (73% women, mean age 53.0±14.3 years), 15% (n=48) had high PAWP. Group 1 PH+high PAWP demonstrated greater obesity, left ventricular hypertrophy ( P <0.0002), left ventricular strain impairment ( P <0.0001), and decreased left ventricular compliance ( P <0.0001) compared with group 1 PH+normal PAWP, with changes comparable to Cpc-PH HFpEF (n=75). Compared with Cpc-PH HFpEF, left atrial function was better in group 1 PH+high PAWP with lower PAWP V wave, higher left atrial compliance, and left atrial ejection fraction ( P <0.0001 for all). Metabolomics demonstrated little difference between group 1 PH with high versus normal PAWP but large differences between group 1 PH+high PAWP versus Cpc-PH HFpEF (100 metabolites altered at false discovery rate P <0.05). Elevated PAWP was also observed in 18% of group 1 PH in the validation cohort 1 (n=402), with exercise PAWP response intermediately abnormal in group 1 PH+high PAWP relative to Cpc-PH HFpEF and group 1 PH+normal PAWP (interaction P <0.0001). Elevated PAWP was similarly observed in 22% and 19% of group 1 PH in validation cohorts 2 (n=55) and 3 (n=787), respectively. CONCLUSIONS: Approximately 1 in 5 adjudicated patients with group 1 PH has elevation in resting PAWP despite severe pulmonary vascular dysfunction and metabolomics consistent with traditionally defined group 1 PH. Despite resting PAWP elevation, these patients with group 1 PH were metabolomically and biologically distinct from Cpc PH HFpEF, with better left atrial function and diastolic reserve during exercise. These data emphasize the limitations of using resting PAWP alone to separate group 1 PH from HFpEF and call for development of more integrated clinical diagnostic criteria.
Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension
Reddy, Yogesh N.V. , Frantz, Robert P. , Hemnes, Anna R. , Hassoun, Paul M. , Horn, Evelyn M. , Leopold, Jane A. , Rosenzweig, Erika B. , Hill, Nicholas S. , Erzurum, Serpil C. , Beck, Gerald J. , Finet, J. Emanuel , Jellis, Christine , Mathai, Stephen C. , Group, the PVDOMICS Study, Rosenzweig, Erika B , Hill, Nicholas S , Erzurum, Serpil C , Beck, Gerald J , Finet, J Emanuel , Jellis, Christine L , Mathai, Stephen C , Tang, W H Wilson , Borlaug, Barry A , Nishimura, Rick , Frantz, Robert P , Hemnes, Anna , Horn, Evelyn M , Leopold, Jane A , Hassoun, Paul M , Rischard, Franz , Tang, W.H. Wilson , Borlaug, Barry A. , Group, the PVDOMICS Study

Mayo Clinic

Circulation: Heart Failure | December 3, 2025 | Volume: 19 | Issue: 1 | Pages: No page available

10.1161/circheartfailure.125.013591 | PMID 41332382 Get It

BACKGROUND: Although obesity and insulin resistance (IR) are established risk factors for left heart dysfunction, their clinical impact in group 1 pulmonary hypertension (PH) remains unclear. We sought to determine the impact of excess adiposity versus IR on biventricular hemodynamic and functional reserve in group 1 PH. METHODS: Homeostasis model of insulin resistance and adiposity indices (body mass index [BMI], fat mass, waist circumference) were measured among group 1 patients with PH recruited to PVDOMICS (Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics). Functional capacity, and dynamic pulmonary capillary wedge pressure (PCWP) and right atrial pressure responses were compared stratified by obesity (BMI≥30 kg/m 2 ) and IR status (HOMA-IR≥2.6) using repeated-measure mixed models. RESULTS: Among patients with group 1 PH (n=418), 158 (38%) had BMI≥30 kg/m 2 (94 [60%] of whom had IR), and 260 (62%) had BMI<30 kg/m 2 (74 [28%] of whom had IR). Among those with waist circumference measurement (n=375), 287 (77%) had excess adiposity by elevated waist/height ratio, with 214 (57%) having elevated waist circumference. Patients with obesity had worse quality of life, exercise capacity and left heart remodeling, along with higher resting/dynamic PCWP, right atrial pressure and cardiac output ( P <0.0001 for all). Higher PCWP response with obesity persisted after adjusting for IR (IR-adjusted PCWP+2.5 mm Hg [95% CI, +1.4 to +3.6]; P <0.0001). All adiposity indices were consistently associated with PCWP response, but IR was not. Similar associations were observed between adiposity indices with higher right atrial pressure and cardiac output. Greater visceral adiposity as measured by body shape index (hazard ratio, 2.01 [95% CI, 1.16–3.47]; P =0.01) or weight-adjusted waist index (hazard ratio, 1.64 [95% CI, 1.10–2.46]; P =0.01) was associated with worse survival. CONCLUSIONS: Excess adiposity is common in group 1 PH, occurring in 4 out of 5 patients by the more sensitive waist/height ratio, in contrast to only 2 out of 5 patients having obesity by traditional BMI criteria. Excess adiposity is associated with higher biventricular filling pressures, cardiac output demand, worse functional status and reduced survival. These data support trials of adipose-reducing therapies in patients with group 1 PH and excess adiposity.
Abstract 4367166: A Multicenter Study of Detection of Pulmonary Hypertension Based on Point-of-Care 12- Lead ECG Data
Agarwal, Richa , Wieczorek, Mikolaj A. , Hackett, Sarah, Carlson, Katherine , Klugherz, Paul, Wagner, Tyler , DuBrock, Hilary M. , Johnson, Patrick W. , Frantz, Robert P. , Strom, Jordan B. , Waks, Jonathan W. , Hemnes, Anna R. , Steinberg, Benjamin A. , Pandey, Ambarish , Hackett, Sarah, Alger, Heather M. , Carter, Rickey E. , Wagner, Tyler

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4367166 Get It

Background: Pulmonary hypertension (PH) is a life-threatening disease affecting up to 1% of the global population. Diagnosis can be challenging and is often delayed due to the need for advanced imaging and invasive procedures. The use of artificial intelligence applied to ECGs (ECG-AI) has been shown to detect subtle patterns in voltage-time data and may be a valuable tool for the early detection of PH. Hypothesis and Purpose: To evaluate the performance of a previously trained, ECG-AI algorithm to detect PH (ECG-AI PH) using real-world data (RWD) collected in a multicenter, validation study. A joint primary hypothesis required sensitivity (Sn), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) to exceed the null values of 76%, 70%, 10% and 90%. Study Design and Methods: This retrospective validation study was conducted at 5 geographically diverse U.S. health systems. Adult subjects were eligible for inclusion if they had a 12-lead ECG paired with an echocardiogram (Echo) in which tricuspid regurgitation velocity (TRV) was recorded, following presentation with dyspnea. Patients were classified according to echocardiographic criteria as either PH (PH+, TRV >3.4 m/s) or controls (PH-, TRV ≤2.8 m/s) to simulate the real-world use of ECG-AI, where a positive result could lead to a follow-up Echo. The study database was locked before processing the digital ECGs with ECG-AI PH. Performance was also estimated in a subset of subjects that later had a right heart catheterization using mPAP ≥ 20mmHg as the definition of PH. Results: A total of 14281 subjects (53% female, 63% aged 50+ years) met the inclusion criteria, including 3019 PH+ cases and 11262 PH- controls (Figure). Sn and Sp were 84.0% (95% CI: 82.6%, 85.3%) and 71.7% (95% CI: 70.9%, 72.6%), respectively. The positive and negative predictive values were 18.9% (95% CI: 18.4%, 19.4%) and 98.3% (95% CI: 98.1%, 98.4%), respectively, at 7.3% prevalence. Each endpoint met pre-defined performance criteria. In the subset of 1683 subjects with a follow up RHC, performance remained robust (Sn 85% (1155/1358); Sp 46% (151/325)). Conclusion: While ECG-AI PH was first developed as an investigational tool to detect PH, continued development as software as a medical device for clinical use demonstrated that the algorithm retained strong performance to detect PH in diverse, non-overlapping clinical settings and patient populations.
Abstract 4367109: Evaluation of a Novel Artificial Intelligence Electrocardiogram Tool for Early Identification of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Carlson, Katherine , Wagner, Tyler , DuBrock, Hilary M. , Alger, Heather M. , Frantz, Robert P.

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4367109 Get It

Introduction: Pulmonary hypertension (PH) is a life-threatening, progressive disease with non-specific symptoms, often leading to delayed diagnosis. Early identification of World Health Organization Group 1 (Pulmonary Arterial Hypertension, PAH) and Group 4 (Chronic Thromboembolic Pulmonary Hypertension, CTEPH) is essential, as effective therapies can improve outcomes. Hypothesis: An electrocardiogram-based AI algorithm for PH detection (ECG-AI PH) may enable earlier diagnosis and reduce healthcare utilization, including hospitalizations and procedures. Methods: Retrospective analysis used a de-identified data platform of >7M clinical records from a multistate integrated health system. Adult precapillary PH patients (mPAP >20 mmHg, PVR >2 WU, PCWP ≤15 mmHg) were identified as PAH or CTEPH based on ICD codes, use of approved therapies, or surgical interventions (for CTEPH) between 2002 and 2024. ECG-AI PH was applied to ECGs within 30 days of diagnostic right heart catheterization, using a 5:1 randomly sampled PH-negative control cohort. Training set patients were excluded. Clinical event frequency was compared between two intervals: from first possible PH symptom (dyspnea, syncope, chest pain, fatigue, lower limb swelling) to diagnosis, and from symptom onset to first positive ECG-AI PH prediction. Results: A total of 1882 PAH and 359 CTEPH patients met inclusion criteria. Of these, 1340 PAH and 258 CTEPH patients had symptom codes prior to diagnosis. Both groups showed prolonged intervals from symptom onset to diagnosis, with multiple diagnostic procedures and hospitalizations (Figure). ECG-AI PH performance evaluation on the test set included 647 PAH and 152 CTEPH patients. ECG-AI PH achieved AUCs of 0.90 and 0.89 for PAH and CTEPH, sensitivities of 80.3% and 76.8%, and specificities of 83.4% and 82.4%. Among those tested, 576 PAH and 95 CTEPH patients had a positive ECG-AI PH prediction after symptom onset but before diagnosis. Compared to the current patient journey, the interval between initial symptoms and a positive output from ECG-AI PH was shorter and had fewer diagnostic tests/visits. Conclusion: ECG-AI PH demonstrated strong performance in detecting PAH and CTEPH. It may reduce diagnostic delays, support earlier PH-focused screening (e.g., echocardiograms evaluating the right heart), enable earlier intervention, and reduce pre-diagnosis healthcare burden, benefitting both patient outcomes and healthcare system efficiency.
Abstract 4366623: Metabolomics of Right Ventricular Systolic Function Across the Spectrum of Pulmonary Hypertension – insights from the PVDOMICS Cohort
Chung, Samuel, Chacon-Barahona, Jonathan , Simpson, Catherine E. , Mathai, Stephen C. , Krumsiek, Jan, Racanelli, Alexandra C. , Mathai, Stephen C , Simpson, Catherine E , Garry, Jonah , Chung, Samuel, Frantz, Robert P. , Rischard, Franz , Hassoun, Paul M. , Krumsiek, Jan , Brittain, Evan L , Hemnes, Anna R. , Horn, Evelyn M.

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4366623 Get It

Introduction: PH increases RV afterload, often leading to RV systolic and diastolic failure. The metabolic mechanisms underlying RV dysfunction remain poorly understood and are largely unexplored across non-PAH forms of PH. Aims: We aimed to identify which metabolites and metabolic pathways associated with imaging measures of RV systolic function. Methods: We analyzed data from the multi-center PVDOMICS cohort, which includes echo, CMR, invasive hemodynamics, clinical phenotyping, and untargeted plasma metabolomics (via Metabolon). RV systolic function metrics selected as the outcome measures for this study were fractional area change (echo), global longitudinal strain (echo), and RVEF (CMR). Associations between non-xenobiotic, named metabolites and RV function measures were assessed using linear regression adjusted for age, sex, BMI, and PH group, with significance defined by FDR <0.05. Metabolite set enrichment analysis (MSEA) was performed to identify significantly enriched pathways (FDR <0.20). To complement MSEA, we conducted mean-aggregation analysis: we averaged metabolite concentrations within each pathway and tested associations with RV function using the same covariate adjustments (FDR <0.05). Results: We identified 979 participants with plasma metabolomics and at least one available outcome measure (317 Group 1 PH; 106 Group 2 PH; 140 Group 3 PH; 51 Group 4 PH; 26 Group 5 PH; 81 Healthy Controls; 258 Disease Comparators). Linear regression identified 170 metabolites from the 647 named metabolites significantly associated with all 3 RV metrics (Top 10 by average ranked p-value displayed in Image 1 ). MSEA revealed seven enriched pathways across all RV metrics: Androgenic Steroids, Pregnenolone Steroids, Progestin Steroids, Fatty Acid Metabolism (Acyl Choline), Histidine metabolism, Vitamin A metabolism, Gamma-glutamyl Amino Acid ( Image 2) . Mean aggregation analysis showed that higher concentrations of Androgenic/Pregnenolone Steroids and Vitamin A metabolites strongly associated with improved RV function, while higher levels of Fatty Acid Metabolism (Acyl Carnitine) and Acetylated Peptides associated with worse function ( Image 3 ). Conclusions: Using data from the multi-institutional PVDOMICS cohort, we provide a blueprint of metabolites and metabolic pathways associated with RV systolic function across the spectrum of PH. Steroid hormones as well as Vitamin A and fatty acid metabolites emerged as central to RV systolic function.
A tale of 2 pathologies: unraveling chronic thromboembolic pulmonary hypertension and pulmonary veno-occlusive disease in pulmonary hypertension
Kohli, Akshay , Frantz, Robert P. , Boland, Jennifer M. , Frantz, Robert P , DuBrock, Hilary M. , Kennedy, Cassie C.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | October 24, 2025 | Volume: 212 | Issue: 2 | Pages: 356-360

10.1164/rccm.202505-1140im | PMID 41135029 Get It

Pulmonary artery size on computed tomography associates with mean pulmonary artery pressure and mortality
Couch, Tyler J, Beck, Gerald J. , Rozenzweig, Erika B, Erzurum, Serpil C. , Frantz, Robert P. , Hassoun, Paul M. , Hill, Nicholas S. , Lempel, Jason K. , Nian, Hui , Ray, David N, Schwalbach, Kevin T. , Group, the PVDOMICS Study, Hemnes, Anna , Frantz, Robert P , Terry, James G , Couch, T J, Carr, J. Jeffrey , Hassoun, Paul M. , Horn, Evelyn M. , Leopold, Jane A. , Rischard, Franz , Terry, James G. , Hemnes, Anna R. , Group, the PVDOMICS Study

Mayo Clinic

Annals of the American Thoracic Society | October 15, 2025 | Volume: 23 | Issue: 4 | Pages: 494-505

10.1513/annalsats.202507-831oc | PMID 41092241 Get It

Abstract Rationale Pulmonary artery (PA) dilation on computed tomography (CT) has been associated with moderate-to-severe ­pulmonary hypertension (PH) using outdated diagnostic criteria. The association between PA size and mean PA pressure (mPAP) in mild PH and the prognostic implications of PA dilation remain unclear. Objectives To investigate associations between PA size, mPAP, and survival in subjects without significant lung disease aside from PH. Methods PA size on CT was measured for individuals with group 1 or 2 PH and matched controls in the Pulmonary Vascular Disease Phenomics cohort. Outcomes included mPAP on right heart catheterization (RHC) and time to heart and/or lung ­transplantation or death. Measurements and Main Results A total of 691 subjects were included, with 595 undergoing RHC. PA diameter and PA:aorta ratio demonstrated significant association with mPAP (ρ = 0.557 and 0.564, respectively). Size increased incrementally from no PH to mild PH to moderate-severe PH for PA diameter (27.64 [95% CI, 17.64-37.64] mm to 30.65 [95% CI, 18.99-42.31] mm to 36.00 [95% CI, 22.46-49.54] mm) and PA:aorta (0.89 [95% CI, 0.53-1.24] to 0.99 [95% CI, 0.63-1.35] to 1.19 [95% CI, 0.60-1.78]). PA diameter and PA:aorta demonstrated good discrimination of mPAP &gt;20 mm Hg (area under the curve: 0.834 and 0.816, respectively). Transplant-free survival decreased across the continuum of PA diameter and PA:aorta (P &lt;.001). Adjusted hazard ratio of third versus first quartile values was 2.36 (95% CI, 1.58-3.54) for PA diameter and 2.24 (95% CI, 1.52-3.30) for PA:aorta. Conclusions In subjects without significant lung disease outside of PH, PA size on CT was associated with increased mPAP and decreased transplant-free survival across the spectrum of PH severity and demonstrated modest diagnostic discriminatory ability using updated hemodynamic criteria.
Evaluating Measurement Stability in Glioblastomas Using Magnetic Resonance Elastography: Repeatability and Interobserver Agreement
Friismose, Ancuta Ioana , Aunan‐Diop, Jan Saip , Dahlrot, Rikke Hedegaard , Harbo, Frederik Severin Gråe , Jensen, Janni , Ehman, Richard L. , Hojo, Emi , Graumann, Ole , Mussmann, Bo Redder , Friismose, Ancuta I , Ehman, Richard , Hojo, Emi , Mussmann, Bo , Pedersen, Michael , Huston, John , Poulsen, Frantz Rom

Mayo Clinic

Journal of Magnetic Resonance Imaging | October 8, 2025 | Volume: 63 | Issue: 3 | Pages: 774-782

10.1002/jmri.70145 | PMID 41061165 Get It

ABSTRACT Background Magnetic resonance elastography (MRE) has demonstrated potential in characterizing intracranial tumors, including glioblastoma. The influence of pathology on measurement consistency and interobserver agreement needs evaluation to promote MRE implementation as a quantitative biomarker. Purpose To assess repeatability and interobserver agreement of absolute and normalized magnitude of the complex shear modulus (| G *|), storage modulus ( G ′), and loss modulus ( G ″) in glioblastoma. Study Type Prospective. Population Thirteen adults (5 male, 8 female, mean age 66.23 years) with histopathologically confirmed glioblastoma. Field Strength/Sequence 3 T MRI, modified single‐shot spin‐echo echo‐planar imaging. Assessment Two same‐session MRE acquisitions were performed with patient repositioning. The solid tumor component was independently segmented by 2 observers on contrast‐enhanced T1‐weighted images co‐registered to MRE maps. Statistical Tests Repeatability was assessed using the repeatability coefficient, coefficient of variation, and Bland–Altman plots, and interobserver agreement by the intraclass correlation coefficient. The Wilcoxon signed‐rank test compared parameters and coefficients of variation between tumor‐normal‐appearing white matter and absolute and normalized measurements. Significance was set at 0.05. Results Tumor | G *| and G ′ showed repeatability coefficients of 0.07–0.08 kPa and 0.05 kPa, compared with 0.13 kPa (| G *|) and 0.15–0.16 kPa ( G ′) for normalized measurements. Coefficients of variation in tumor regions were 1.42% ± 1.12%–1.60% ± 1.41% for | G *| and 1.19% ± 0.96%–2.08% ± 2.22% for G ′, significantly lower than normalized values (4.82% ± 4.49%–4.21% ± 4.27% for | G *|; 5.12% ± 5.04%–5.45% ± 4.53% for G ′). Tumor | G *| and G ′ showed excellent interobserver agreement (intraclass correlation coefficients 0.97 and 0.95). Tumor G ″ demonstrated higher variability than | G *| and G ′ (coefficients of variation 8.58% ± 7.69%–7.51% ± 6.73%), with no significant difference between absolute and normalized measurements ( p = 0.14). Data Conclusion Tumor | G *| and G ′ are the most repeatable metrics in glioblastoma. Normalization reduces measurement repeatability due to normal‐appearing white matter variability. The small sample size ( n = 13) limits generalizability. Evidence Level 2. Technical Efficacy Stage 2.